The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to CYP2C19*2 genotype: first experience in patients. [electronic resource]
Producer: 20100520Description: 43-53 p. digitalISSN:- 1538-7836
- Adenosine Diphosphate
- Administration, Oral
- Aged
- Angioplasty, Balloon, Coronary -- instrumentation
- Aryl Hydrocarbon Hydroxylases -- genetics
- Aspirin -- therapeutic use
- Blood Coagulation -- drug effects
- Blood Platelets -- drug effects
- Cell Adhesion Molecules -- blood
- Clopidogrel
- Collagen -- therapeutic use
- Coronary Artery Disease -- therapy
- Cytochrome P-450 CYP2C19
- Cytochrome P-450 CYP3A -- genetics
- Drug Therapy, Combination
- Female
- Gene Frequency
- Genotype
- Humans
- Male
- Microfilament Proteins -- blood
- Middle Aged
- Phenotype
- Phosphoproteins -- blood
- Phosphorylation
- Platelet Aggregation -- drug effects
- Platelet Aggregation Inhibitors -- administration & dosage
- Polymorphism, Genetic
- Purinergic P2 Receptor Antagonists
- Quinazolinones -- administration & dosage
- Receptors, Purinergic P2 -- metabolism
- Receptors, Purinergic P2Y12
- Stents
- Sulfonamides -- administration & dosage
- Thrombelastography
- Ticlopidine -- analogs & derivatives
- Vasodilator-Stimulated Phosphoprotein
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.